SCHEDULE: ARK Investment Management Discloses Strata Medical Stake

ARK Investment Management LLC and Catherine D. Wood have jointly filed a Schedule 13G, reporting beneficial ownership of 8.57% of Strata Critical Medical, Inc. common stock as of March 31, 2026.

Summary

• ARK Investment Management LLC and Catherine D. Wood have filed an amendment to their Schedule 13G, reporting their beneficial ownership of Strata Critical Medical, Inc. common stock.
• As of March 31, 2026, the total beneficial ownership reported is 7,455,284 shares, representing 8.57% of the class of securities.
• ARK Investment Management LLC holds sole voting and dispositive power over these shares.
• Catherine D. Wood holds shared voting and dispositive power over these shares.
• The filing confirms that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a standard disclosure of beneficial ownership and does not provide new operational or financial information about the issuer.

Positives

• ARK Investment Management LLC and Catherine D. Wood maintain a significant stake (8.57%) in Strata Critical Medical, Inc., indicating confidence in the company's prospects.
• The filing is an amendment to a Schedule 13G, suggesting ongoing monitoring and reporting of holdings, which is standard practice for institutional investors.

Risks

• The filing does not contain specific risk factors related to Strata Critical Medical, Inc. itself, as it is a disclosure of ownership by ARK Investment Management LLC.
• Potential risks for ARK Investment Management LLC could include market volatility affecting the value of their Strata Critical Medical, Inc. holdings.

Future Outlook

The filing does not contain forward-looking statements or guidance from Strata Critical Medical, Inc. It is a disclosure of ownership by ARK Investment Management LLC.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11."
• Kellen Carter, Chief Compliance Officer, ARK Investment Management LLC
• Catherine D. Wood, Chief Executive Officer, Chief Investment Officer

Industry Context

StockSavvy.ai notes that this filing is a routine Schedule 13G amendment, indicating ARK Investment Management's continued significant investment in Strata Critical Medical, Inc. Such filings are common for institutional investors to disclose substantial ownership stakes.

Stakeholder Impact

• Shareholders of Strata Critical Medical, Inc. are informed of ARK Investment Management's substantial and ongoing investment, which may be perceived positively.
• The confirmation that shares are held in the ordinary course of business reassures that ARK is not currently seeking to influence control, which is a standard assurance for such filings.

Key Dates

Keywords

Schedule 13G, ARK Investment Management, Catherine D. Wood, Strata Critical Medical, Beneficial Ownership, SEC Filing, Common Stock, Investment Management